vs

Side-by-side financial comparison of Dexcom (DXCM) and Sally Beauty Holdings, Inc. (SBH). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $943.2M, roughly 1.3× Sally Beauty Holdings, Inc.). Dexcom runs the higher net margin — 21.2% vs 4.8%, a 16.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 0.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 1.9%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Sally Beauty Holdings, Inc. is an American international specialty retailer and distributor of professional beauty supplies with revenues of more than $3.9 billion annually.

DXCM vs SBH — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$943.2M
SBH
Growing faster (revenue YoY)
DXCM
DXCM
+21.0% gap
DXCM
21.6%
0.6%
SBH
Higher net margin
DXCM
DXCM
16.4% more per $
DXCM
21.2%
4.8%
SBH
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
1.9%
SBH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
SBH
SBH
Revenue
$1.3B
$943.2M
Net Profit
$267.3M
$45.6M
Gross Margin
62.9%
51.2%
Operating Margin
25.6%
8.1%
Net Margin
21.2%
4.8%
Revenue YoY
21.6%
0.6%
Net Profit YoY
153.6%
-25.3%
EPS (diluted)
$0.67
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
SBH
SBH
Q1 26
$1.3B
Q4 25
$1.3B
$943.2M
Q3 25
$1.2B
$947.1M
Q2 25
$1.2B
$933.3M
Q1 25
$1.0B
$883.1M
Q4 24
$1.1B
$937.9M
Q3 24
$994.2M
$935.0M
Q2 24
$1.0B
$942.3M
Net Profit
DXCM
DXCM
SBH
SBH
Q1 26
$267.3M
Q4 25
$267.3M
$45.6M
Q3 25
$283.8M
$49.9M
Q2 25
$179.8M
$45.7M
Q1 25
$105.4M
$39.2M
Q4 24
$151.7M
$61.0M
Q3 24
$134.6M
$48.1M
Q2 24
$143.5M
$37.7M
Gross Margin
DXCM
DXCM
SBH
SBH
Q1 26
62.9%
Q4 25
62.9%
51.2%
Q3 25
60.5%
52.2%
Q2 25
59.5%
51.5%
Q1 25
56.9%
52.0%
Q4 24
58.9%
50.8%
Q3 24
59.7%
51.2%
Q2 24
62.4%
51.0%
Operating Margin
DXCM
DXCM
SBH
SBH
Q1 26
25.6%
Q4 25
25.6%
8.1%
Q3 25
20.1%
8.4%
Q2 25
18.4%
8.4%
Q1 25
12.9%
7.9%
Q4 24
17.0%
10.7%
Q3 24
15.3%
8.8%
Q2 24
15.7%
7.6%
Net Margin
DXCM
DXCM
SBH
SBH
Q1 26
21.2%
Q4 25
21.2%
4.8%
Q3 25
23.5%
5.3%
Q2 25
15.5%
4.9%
Q1 25
10.2%
4.4%
Q4 24
13.6%
6.5%
Q3 24
13.5%
5.1%
Q2 24
14.3%
4.0%
EPS (diluted)
DXCM
DXCM
SBH
SBH
Q1 26
$0.67
Q4 25
$0.67
$0.45
Q3 25
$0.70
$0.49
Q2 25
$0.45
$0.44
Q1 25
$0.27
$0.38
Q4 24
$0.37
$0.58
Q3 24
$0.34
$0.45
Q2 24
$0.35
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
SBH
SBH
Cash + ST InvestmentsLiquidity on hand
$917.7M
$157.2M
Total DebtLower is stronger
$842.5M
Stockholders' EquityBook value
$2.7B
$823.6M
Total Assets
$6.3B
$2.9B
Debt / EquityLower = less leverage
1.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
SBH
SBH
Q1 26
$917.7M
Q4 25
$917.7M
$157.2M
Q3 25
$1.8B
$149.2M
Q2 25
$1.2B
$112.8M
Q1 25
$904.9M
$92.2M
Q4 24
$606.1M
$105.5M
Q3 24
$621.2M
$108.0M
Q2 24
$939.2M
$97.4M
Total Debt
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
$842.5M
Q3 25
$862.0M
Q2 25
$882.4M
Q1 25
$902.8M
Q4 24
$938.1M
Q3 24
$978.3M
Q2 24
$978.9M
Stockholders' Equity
DXCM
DXCM
SBH
SBH
Q1 26
$2.7B
Q4 25
$2.7B
$823.6M
Q3 25
$2.7B
$794.2M
Q2 25
$2.6B
$762.9M
Q1 25
$2.3B
$699.8M
Q4 24
$2.1B
$656.5M
Q3 24
$2.0B
$628.5M
Q2 24
$2.4B
$577.7M
Total Assets
DXCM
DXCM
SBH
SBH
Q1 26
$6.3B
Q4 25
$6.3B
$2.9B
Q3 25
$7.5B
$2.9B
Q2 25
$7.3B
$2.7B
Q1 25
$6.8B
$2.7B
Q4 24
$6.5B
$2.7B
Q3 24
$6.4B
$2.8B
Q2 24
$6.8B
$2.7B
Debt / Equity
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
1.02×
Q3 25
1.09×
Q2 25
1.16×
Q1 25
1.29×
Q4 24
1.43×
Q3 24
1.56×
Q2 24
1.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
SBH
SBH
Operating Cash FlowLast quarter
$93.2M
Free Cash FlowOCF − Capex
$57.5M
FCF MarginFCF / Revenue
6.1%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
2.05×
TTM Free Cash FlowTrailing 4 quarters
$216.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
$294.0M
$93.2M
Q3 25
$659.9M
$120.9M
Q2 25
$303.0M
$69.4M
Q1 25
$183.8M
$51.1M
Q4 24
$301.4M
$33.5M
Q3 24
$199.5M
$110.7M
Q2 24
$279.4M
$47.9M
Free Cash Flow
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
$192.1M
$57.5M
Q3 25
$579.4M
$78.0M
Q2 25
$208.9M
$49.1M
Q1 25
$96.8M
$32.2M
Q4 24
$176.8M
$13.4M
Q3 24
$88.3M
$73.3M
Q2 24
$213.3M
$28.7M
FCF Margin
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
15.3%
6.1%
Q3 25
47.9%
8.2%
Q2 25
18.1%
5.3%
Q1 25
9.3%
3.6%
Q4 24
15.9%
1.4%
Q3 24
8.9%
7.8%
Q2 24
21.2%
3.1%
Capex Intensity
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
8.1%
3.8%
Q3 25
6.7%
4.5%
Q2 25
8.1%
2.2%
Q1 25
8.4%
2.1%
Q4 24
11.2%
2.1%
Q3 24
11.2%
4.0%
Q2 24
6.6%
2.0%
Cash Conversion
DXCM
DXCM
SBH
SBH
Q1 26
Q4 25
1.10×
2.05×
Q3 25
2.33×
2.42×
Q2 25
1.69×
1.52×
Q1 25
1.74×
1.30×
Q4 24
1.99×
0.55×
Q3 24
1.48×
2.30×
Q2 24
1.95×
1.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

SBH
SBH

Sally Beauty Supply$531.6M56%
Beauty Systems Group$411.6M44%

Related Comparisons